Wesley T O'Neal1, Virginia J Howard2, Dawn Kleindorfer3, Brett Kissela3, Suzanne E Judd4, Leslie A McClure4, Mary Cushman5, George Howard4, Elsayed Z Soliman6. 1. Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA woneal@wakehealth.edu. 2. Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA. 3. Department of Neurology, University of Cincinnati, Cincinnati, OH, USA. 4. Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA. 5. Department of Medicine, University of Vermont, Burlington, VT, USA. 6. Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA Epidemiological Cardiology Research Center (EPICARE), Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Abstract
AIMS: To determine if the association between electrocardiographic left ventricular hypertrophy (ECG-LVH) and ischaemic stroke is partially explained by the concomitant presence of QT prolongation. METHODS AND RESULTS: A total of 24 948 (mean age = 65 ± 9.4 years; 40% black; 55% women) participants from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study were included in this analysis. Electrocardiographic left ventricular hypertrophy was defined by the Sokolow-Lyon criteria. Heart rate-adjusted QT (QTa) was computed using a linear regression model. Adjudicated ischaemic stroke events were the outcome of interest. Cox regression was used to compute hazard ratios (HRs) and 95% confidence intervals (CIs) for associations between ECG-LVH and prolonged QTa, in isolation and combined, with ischaemic stroke. There were 2422 (9.7%) participants with ECG-LVH, 820 (3.3%) with prolonged QTa, and 161 (0.6%) with both. Over a median follow-up of 7.6 years, 714 (2.9%) ischaemic stroke events occurred. After adjustment for stroke risk factors and potential confounders, an increased risk of ischaemic stroke was observed among participants with ECG-LVH and prolonged QTa (HR = 1.85, 95% CI = 1.04-3.30), isolated ECG-LVH (HR = 1.40, 95% CI = 1.13-1.75), and isolated prolonged QTa (HR = 1.45, 95% CI = 1.04-2.03) compared with participants without either condition. When ECG-LVH and prolonged QTa were examined as separate variables, the risk of ischaemic stroke for each condition remained statistically significant. CONCLUSION: The combination of ECG-LVH and prolonged QT is associated with a higher risk of ischaemic stroke compared with either condition in isolation, and the stroke risk for each condition does not depend on the presence of the other. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: To determine if the association between electrocardiographic left ventricular hypertrophy (ECG-LVH) and ischaemic stroke is partially explained by the concomitant presence of QT prolongation. METHODS AND RESULTS: A total of 24 948 (mean age = 65 ± 9.4 years; 40% black; 55% women) participants from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study were included in this analysis. Electrocardiographic left ventricular hypertrophy was defined by the Sokolow-Lyon criteria. Heart rate-adjusted QT (QTa) was computed using a linear regression model. Adjudicated ischaemic stroke events were the outcome of interest. Cox regression was used to compute hazard ratios (HRs) and 95% confidence intervals (CIs) for associations between ECG-LVH and prolonged QTa, in isolation and combined, with ischaemic stroke. There were 2422 (9.7%) participants with ECG-LVH, 820 (3.3%) with prolonged QTa, and 161 (0.6%) with both. Over a median follow-up of 7.6 years, 714 (2.9%) ischaemic stroke events occurred. After adjustment for stroke risk factors and potential confounders, an increased risk of ischaemic stroke was observed among participants with ECG-LVH and prolonged QTa (HR = 1.85, 95% CI = 1.04-3.30), isolated ECG-LVH (HR = 1.40, 95% CI = 1.13-1.75), and isolated prolonged QTa (HR = 1.45, 95% CI = 1.04-2.03) compared with participants without either condition. When ECG-LVH and prolonged QTa were examined as separate variables, the risk of ischaemic stroke for each condition remained statistically significant. CONCLUSION: The combination of ECG-LVH and prolonged QT is associated with a higher risk of ischaemic stroke compared with either condition in isolation, and the stroke risk for each condition does not depend on the presence of the other. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: M L Bots; Y Nikitin; J T Salonen; P C Elwood; S Malyutina; A Freire de Concalves; J Sivenius; A Di Carlo; P Lagiou; J Tuomilehto; P J Koudstaal; D E Grobbee Journal: J Epidemiol Community Health Date: 2002-02 Impact factor: 3.710
Authors: Elsayed Z Soliman; George Howard; James F Meschia; Mary Cushman; Paul Muntner; Patrick M Pullicino; Leslie A McClure; Suzanne Judd; Virginia J Howard Journal: Stroke Date: 2011-08-04 Impact factor: 7.914
Authors: Tetsuya Ohira; Eyal Shahar; Lloyd E Chambless; Wayne D Rosamond; Thomas H Mosley; Aaron R Folsom Journal: Stroke Date: 2006-08-24 Impact factor: 7.914
Authors: Aditya Jain; Harikrishna Tandri; Darshan Dalal; Harjit Chahal; Elsayed Z Soliman; Ronald J Prineas; Aaron R Folsom; João A C Lima; David A Bluemke Journal: Am Heart J Date: 2010-04 Impact factor: 4.749
Authors: Elsayed Z Soliman; George Howard; Mary Cushman; Brett Kissela; Dawn Kleindorfer; Anh Le; Suzanne Judd; Leslie A McClure; Virginia J Howard Journal: J Am Coll Cardiol Date: 2012-04-17 Impact factor: 24.094
Authors: Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Hans Wedel; Lars H Lindholm; Björn Dahlöf Journal: JAMA Date: 2004-11-17 Impact factor: 56.272
Authors: Gargya Malla; D Leann Long; Suzanne E Judd; Marguerite R Irvin; Brett M Kissela; Daniel T Lackland; Monika M Safford; Deborah A Levine; Virginia J Howard; George Howard; J David Rhodes; Jenifer H Voeks; Dawn O Kleindorfer; Aaron Anderson; James F Meschia; April P Carson Journal: Diabetes Care Date: 2019-08-07 Impact factor: 19.112
Authors: Evgeniya Reshetnyak; Mariella Ntamatungiro; Laura C Pinheiro; Virginia J Howard; April P Carson; Kimberly D Martin; Monika M Safford Journal: Stroke Date: 2020-07-16 Impact factor: 10.170
Authors: Xuemei Sui; Virginia J Howard; Michelle N McDonnell; Linda Ernstsen; Matthew L Flaherty; Steven P Hooker; Carl J Lavie Journal: Mayo Clin Proc Date: 2018-06-19 Impact factor: 7.616
Authors: Colton Leavitt; Neil A Zakai; Paul Auer; Mary Cushman; Ethan M Lange; Emily B Levitan; Nels Olson; Timothy A Thornton; Russell P Tracy; James G Wilson; Leslie A Lange; Alex P Reiner; Laura M Raffield Journal: PLoS One Date: 2020-04-02 Impact factor: 3.240